Clinical Trials of Schizophrenia: Optimizing Patient Reported Outcomes and Performance Outcome Assessments
Watch ERT and Cogstate’s recent webinar, “Clinical Trials of Schizophrenia” Webinar, which was presented live on June 10, 2021.
In schizophrenia trials, clinical outcome assessments (COAs) are traditionally clinician reported outcomes (ClinRO). However, there is growing recognition that patient reported and patient performance data contributes valuable information to such studies. Join ERT and Cogstate for “Clinical Trials of Schizophrenia: Optimizing Patient Reported Outcomes and Performance Outcome Assessments,” on June 10 at 11 am ET to learn more. ERT’s Jenny Ly, PhD, Senior Clinical Science Advisor,and Cogstate’s Chris Edgar, PhD, Chief Science Officer, will be discussing the benefits of using PROs and PerfOs to supplement data collected from ClinROs.
Watch on demand now!
Chris Edgar, PhD
Chief Science Officer, Cogstate
Dr. Chris Edgar is an experienced leader in cognitive assessment and clinical endpoint strategy who provides expert guidance to Cogstate’s pharmaceutical customers throughout all stages of trial conduct, from study design and test selection through final analysis. Prior to joining Cogstate, Dr. Edgar oversaw clinical endpoint strategy for multiple neuroscience indications in the Patient-Centered Outcomes Research group at Roche. He holds a PhD in psychopharmacology from Northumbria University and has 20 years of pharmaceutical industry experience. Dr. Edgar has held other key industry positions including Principle Scientist at Roche, Senior Clinical Lead at Bracket/UBC, and Scientific Director at Cognitive Drug Research Ltd.
Jenny Ly, PhD
Senior Clinical Science Advisor, ERT
Jenny Ly is currently a Senior Clinical Science Advisor at ERT. She is clinical psychologist with a specialization in neuropsychology and has over 10 years of experience in the design and management of clinical research. Dr. Ly has extensive experience consulting on best practices for electronic clinical outcome assessments (eCOA) design and implementation as well as optimizing data quality through training for site raters, patients, and caregivers. She is proficient in assessing and working with patients with neurologic and psychiatric disorders. She authored over 15 manuscripts and taught statistical methods courses. She obtained her Ph.D. in Clinical Psychology from The Graduate Center-City University of New York and B.A. from Wellesley College.